
Background: MRI is the gold standard for evaluating silicone breast implants, whether for suspected rupture or screening. This requires dedicated, T2-based silicone-specific sequences (e.g., water-suppressed STIR), which prolong scan time. A T1 Dixon sequence, also routinely acquired in this protocol, offers thinner slices and higher in-plane spatial resolution. Yet no study has tested its non-inferiority to this T2-based diagnostic hallmark on current scanners. We aimed to assess whether a routine T1 Dixon sequence can identify implant rupture accurately enough to obviate the need for the lengthy, dedicated T2 sequences.
Methods: A retrospective, enriched case-control study included 40 women: 20 randomly selected from those whose official report documented rupture in ≥ 1 implant, and 20 randomly selected from women with silicone implants scanned with the identical protocol with a negative report, yielding 66 evaluable implants. The reference standard was the official report, based on the full protocol including dedicated silicone-specific and T2 Dixon sequences. Two blinded readers independently reviewed only the routine T1 Dixon sequence per woman and classified rupture in each implant (yes/no/uncertain).
Results: Of 66 implants, 23 (34.8%) were ruptured according to the reference standard. Sensitivity was identical between readers (21/23, 91.3%), while specificity differed (41/43, 95.3% vs. 35/43, 81.4%; overall accuracy 93.9% vs. 84.8%). Inter-reader agreement was 87.9%. Both readers missed the same implant.
Conclusions: A routine T1 Dixon sequence achieved high sensitivity for implant rupture relative to the reference standard, but specificity varied notably between readers; both missed the same rupture, suggesting an objectively difficult case rather than random error. Given the enriched sample and non-surgical reference standard, these preliminary results are promising but do not yet establish whether dedicated silicone sequences can be safely omitted. A larger prospective study is warranted.